US6576636B2
(en)
*
|
1996-05-22 |
2003-06-10 |
Protarga, Inc. |
Method of treating a liver disorder with fatty acid-antiviral agent conjugates
|
US6326507B1
(en)
|
1998-06-19 |
2001-12-04 |
Trustees Of Dartmouth College |
Therapeutic compounds and methods of use
|
US7435755B2
(en)
|
2000-11-28 |
2008-10-14 |
The Trustees Of Dartmouth College |
CDDO-compounds and combination therapies thereof
|
EP1427407A4
(en)
*
|
2001-03-23 |
2005-05-11 |
Luitpold Pharm Inc |
CONJUGATES BASED ON FATTY AMINES AND PHARMACEUTICAL AGENTS
|
PT1385551E
(pt)
*
|
2001-04-06 |
2008-11-03 |
Wyeth Corp |
Associações antineoplásicas compreendendo cci-779 (derivado de rapamicina) associado a gemcitabina ou fluorouracilo
|
CA2472581C
(en)
|
2002-01-15 |
2012-06-26 |
Trustees Of Dartmouth College |
Tricyclic-bis-enone derivatives and methods of use thereof
|
US7265096B2
(en)
|
2002-11-04 |
2007-09-04 |
Xenoport, Inc. |
Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
|
US20050234009A1
(en)
*
|
2004-03-29 |
2005-10-20 |
Johnson Candace S |
Method of treating solid tumors and leukemias using combination therapy of vitamin D and anti-metabolic nucleoside analogs
|
FR2874016B1
(fr)
|
2004-06-30 |
2006-11-24 |
Centre Nat Rech Scient Cnrse |
Nanoparticules de derives de la gemcitabine
|
KR100699099B1
(ko)
*
|
2004-07-29 |
2007-03-22 |
한미약품 주식회사 |
1-α-할로-2,2-다이플루오로-2-데옥시-D-라이보퓨라노스유도체 및 이의 제조방법
|
WO2006029081A2
(en)
*
|
2004-09-02 |
2006-03-16 |
Neopharm, Inc. |
Nucleoside-lipid conjugates, their method of preparation and uses thereof
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
AU2005316922B2
(en)
*
|
2004-12-17 |
2011-08-25 |
Eli Lilly And Company |
Amide prodrug of gemcitabine, compositions and use thereof
|
NO322682B1
(no)
*
|
2005-03-18 |
2006-11-27 |
Clavis Pharma Asa |
Anvendelse av gemcitabinderivater for fremstilling av orale doseringsformer ved kreftbehandling, samt slike orale doseringsformer
|
KR100680765B1
(ko)
*
|
2005-04-28 |
2007-02-09 |
주식회사 삼천리제약 |
3'-아미노-2',3'-디데옥시구아노신의 제조 방법
|
NO324263B1
(no)
*
|
2005-12-08 |
2007-09-17 |
Clavis Pharma Asa |
Kjemiske forbindelser, anvendelse derav ved behandling av kreft, samt farmasoytiske preparater som omfatter slike forbindelser
|
US8497292B2
(en)
*
|
2005-12-28 |
2013-07-30 |
Translational Therapeutics, Inc. |
Translational dysfunction based therapeutics
|
EP1994042A4
(en)
*
|
2006-02-06 |
2009-03-18 |
Reddys Lab Ltd Dr |
PREPARATION OF GEMCITABINE
|
TWI417095B
(zh)
|
2006-03-15 |
2013-12-01 |
Janssen Pharmaceuticals Inc |
1,4-二取代之3-氰基-吡啶酮衍生物及其作為mGluR2-受體之正向異位性調節劑之用途
|
EA014909B1
(ru)
*
|
2006-06-21 |
2011-02-28 |
Эли Лилли Энд Компани |
Кристаллические формы пролекарства на основе амида гемцитабина, композиции на их основе и их применение
|
WO2008064132A2
(en)
|
2006-11-17 |
2008-05-29 |
Trustees Of Dartmouth College |
Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
|
US8921340B2
(en)
|
2006-11-17 |
2014-12-30 |
Trustees Of Dartmouth College |
Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions
|
CA2670099A1
(en)
|
2006-11-17 |
2008-05-29 |
Trustees Of Dartmouth College |
Synthesis and biological activities of new tricyclic-bis-enones (tbes)
|
TW200845978A
(en)
|
2007-03-07 |
2008-12-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
|
TW200900065A
(en)
|
2007-03-07 |
2009-01-01 |
Janssen Pharmaceutica Nv |
3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
|
KR100957756B1
(ko)
*
|
2007-12-12 |
2010-05-12 |
동우신테크 주식회사 |
2'-데옥시-2',2'-다이플루오로사이티딘의 제조 방법
|
JP5366269B2
(ja)
|
2007-09-14 |
2013-12-11 |
ジャンセン ファーマシューティカルズ, インコーポレイテッド. |
1,3−二置換4−(アリル−x−フェニル)−1h−ピリジン−2−オン
|
ES2356032T3
(es)
|
2007-09-14 |
2011-04-04 |
Ortho-Mcneil-Janssen Pharmaceuticals, Inc. |
4-fenil-3,4,5,6-tetrahidro-2h,1'h-[1,4']bipiridinil-2'-onas 1,3'-disustituidas.
|
CN101815437A
(zh)
*
|
2007-09-26 |
2010-08-25 |
辛乃山医学院 |
氮杂胞苷类似物和其应用
|
DK2082745T3
(da)
*
|
2007-12-28 |
2013-03-25 |
Deutsches Krebsforsch |
Kræftterapi med en parvovirus kombineret med kemoterapi
|
CN101965184B
(zh)
|
2008-01-11 |
2015-03-11 |
里亚塔医药公司 |
合成三萜类化合物的制药用途
|
LT2271658T
(lt)
|
2008-04-18 |
2017-02-27 |
Reata Pharmaceuticals, Inc. |
Antioksidantai uždegimo moduliatoriai:oleanolio rūgšties c-17 patvirtinti dariniai
|
EP2279197B1
(en)
|
2008-04-18 |
2014-11-05 |
Reata Pharmaceuticals, Inc. |
Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring
|
BRPI0911105B1
(pt)
|
2008-04-18 |
2022-11-08 |
Reata Pharmaceuticals, Inc |
Compostos contendo um farmacóforo anti-inflamatório, composição farmacêutica, bem como seus usos
|
WO2009146216A2
(en)
|
2008-04-18 |
2009-12-03 |
Reata Pharmaceuticals. Inc. |
Antioxidant inflammation modulators: novel derivatives of oleanolic acid
|
KR101735807B1
(ko)
|
2008-04-18 |
2017-05-15 |
리타 파마슈티컬스 잉크. |
C-17에 아미노 및 기타 변형을 갖는 올레아놀산 유도체를 포함하는 항산화 염증 조절제
|
FR2931152B1
(fr)
*
|
2008-05-16 |
2010-07-30 |
Centre Nat Rech Scient |
Nouveau systeme de transfert d'acide nucleique
|
JP5758801B2
(ja)
|
2008-07-22 |
2015-08-05 |
トラスティーズ・オブ・ダートマス・カレッジTrustees of Dartmouth College |
単環式シアノエノンおよびその使用方法説明
|
CN102143955B
(zh)
|
2008-09-02 |
2013-08-14 |
Omj制药公司 |
作为代谢型谷氨酸受体调节剂的3-氮杂二环[3.1.0]己烷衍生物
|
WO2010039039A1
(en)
*
|
2008-10-03 |
2010-04-08 |
Clavis Pharma Asa |
Oral formulations of gemcitabine derivatives
|
EP2373649B1
(en)
|
2008-11-28 |
2013-01-23 |
Janssen Pharmaceuticals, Inc. |
Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
|
CN101525361B
(zh)
|
2009-04-21 |
2010-11-17 |
济南圣鲁金药物技术开发有限公司 |
基于吉西他滨结构的前药及其合成方法及应用
|
GB0907551D0
(en)
|
2009-05-01 |
2009-06-10 |
Univ Dundee |
Treatment or prophylaxis of proliferative conditions
|
JP5707390B2
(ja)
|
2009-05-12 |
2015-04-30 |
ジャンセン ファーマシューティカルズ, インコーポレイテッド |
1,2,4−トリアゾロ[4,3−a]ピリジン誘導体およびmGluR2受容体の正のアロステリック調節因子としてのその使用
|
MY153913A
(en)
|
2009-05-12 |
2015-04-15 |
Janssen Pharmaceuticals Inc |
7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
SG10201402250TA
(en)
|
2009-05-12 |
2014-07-30 |
Janssen Pharmaceuticals Inc |
1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
|
RU2012125350A
(ru)
*
|
2009-11-20 |
2013-12-27 |
Клавис Фарма Аса |
Парентеральные препараты производных гемцитабина
|
GB201006181D0
(en)
|
2010-04-14 |
2010-06-02 |
Ayanda As |
Composition
|
ES2536433T3
(es)
|
2010-11-08 |
2015-05-25 |
Janssen Pharmaceuticals, Inc. |
Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
|
EP2661435B1
(en)
|
2010-11-08 |
2015-08-19 |
Janssen Pharmaceuticals, Inc. |
1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
|
CA2814996C
(en)
|
2010-11-08 |
2019-10-01 |
Janssen Pharmaceuticals, Inc. |
1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
|
US9693957B2
(en)
|
2011-07-08 |
2017-07-04 |
The University Of North Carolina At Chapel Hill |
Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
|
EP2739290A4
(en)
*
|
2011-08-02 |
2015-04-15 |
Clovis Oncology Inc |
METHOD FOR SELECTION OF CHEMOTHERAPEUTICS AGAINST ADENOCARCINOMAS
|
CN102432654A
(zh)
*
|
2011-09-26 |
2012-05-02 |
宋云龙 |
吉西他滨酰胺衍生物及其制备方法和用途
|
CN102617679B
(zh)
*
|
2012-03-13 |
2014-11-26 |
北京大学 |
一种共轭亚油酸与吉西他滨连接的前体药物制备方法及其应用
|
EA031986B1
(ru)
|
2012-04-04 |
2019-03-29 |
Галозим, Инк. |
Способ и комбинация для лечения солидной раковой опухоли и набор, содержащий комбинацию
|
US8921419B2
(en)
|
2012-05-08 |
2014-12-30 |
Trustees Of Dartmouth College |
Triterpenoids and compositions containing the same
|
WO2014040073A1
(en)
|
2012-09-10 |
2014-03-13 |
Reata Pharmaceuticals, Inc. |
C13-hydroxy derivatives of oleanolic acid and methods of use thereof
|
JP6420247B2
(ja)
*
|
2012-11-13 |
2018-11-07 |
ボーイエン セラピューティクス,インコーポレイティド |
ゲムシタビンプロドラッグ及びその使用
|
CN103130854A
(zh)
*
|
2013-01-31 |
2013-06-05 |
华东师范大学 |
维生素e琥珀酸酯化吉西他滨前药及应用
|
CN103265594B
(zh)
*
|
2013-03-28 |
2016-05-04 |
东华大学 |
一种藤黄酸酰胺类衍生物及其制备方法和用途
|
CN103159814B
(zh)
*
|
2013-03-28 |
2015-12-23 |
东华大学 |
一种藤黄酸酯类衍生物及其制备方法和用途
|
JO3368B1
(ar)
|
2013-06-04 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
|
JO3367B1
(ar)
|
2013-09-06 |
2019-03-13 |
Janssen Pharmaceutica Nv |
مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
|
US20160250245A1
(en)
*
|
2013-10-21 |
2016-09-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale |
Methods and Pharmaceutical Composition for the Treatment of Polyomavirus Infections
|
CN105873569B
(zh)
|
2013-11-06 |
2020-07-28 |
芝加哥大学 |
用于化疗剂、核酸和光敏剂的递送或共递送的纳米级载体
|
CN109999025A
(zh)
|
2014-01-21 |
2019-07-12 |
詹森药业有限公司 |
包括代谢型谷氨酸能受体亚型2的正别构调节物或正位激动剂的组合及其用途
|
NZ722385A
(en)
|
2014-01-21 |
2019-11-29 |
Janssen Pharmaceutica Nv |
Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
|
WO2015116782A1
(en)
|
2014-01-29 |
2015-08-06 |
Board Of Regents, The University Of Texas System |
Nucleobase analogue derivatives and their applications
|
JP2017530976A
(ja)
|
2014-10-08 |
2017-10-19 |
エピジェネティクス・ファーマ・エルエルシー |
ビタミンe−ヌクレオシド・プロドラッグ
|
WO2017201528A1
(en)
|
2016-05-20 |
2017-11-23 |
The University Of Chicago |
Nanoparticles for chemotherapy, targeted therapy, photodynamic therapy, immunotherapy, and any combination thereof
|
CN111194232B
(zh)
|
2017-08-02 |
2023-01-31 |
芝加哥大学 |
纳米级金属有机层和金属有机纳米片
|
CA3091027A1
(en)
|
2018-02-02 |
2019-08-08 |
Maverix Oncology, Inc. |
Small molecule drug conjugates of gemcitabine monophosphate
|
US20210238214A1
(en)
*
|
2018-04-26 |
2021-08-05 |
NanoMed Holdings Pty Ltd |
Gemcitabine amphiphile prodrugs
|
US20190351031A1
(en)
|
2018-05-16 |
2019-11-21 |
Halozyme, Inc. |
Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20
|
KR102619437B1
(ko)
|
2018-06-29 |
2023-12-29 |
상하이 창청이야오커지 컴퍼니 리미티드 |
젬시타빈의 인-함유 프로드러그
|
CN110054659B
(zh)
*
|
2019-05-05 |
2020-09-11 |
中国医学科学院医药生物技术研究所 |
提高药物抗肿瘤活性的方法
|
US20220396794A1
(en)
|
2019-06-04 |
2022-12-15 |
Apterna Limited |
APTAMERS AGAINST TRANSFERRIN RECEPTOR (TfR)
|
GB202019692D0
(en)
|
2020-12-14 |
2021-01-27 |
Apterna Ltd |
Aptamer-sirna fusions
|